These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25898104)

  • 1. Evolution: Parasite Pressure Favors Fortress-like Defence.
    Graham AL
    Curr Biol; 2015 Apr; 25(8):R335-7. PubMed ID: 25898104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense.
    Westra ER; van Houte S; Oyesiku-Blakemore S; Makin B; Broniewski JM; Best A; Bondy-Denomy J; Davidson A; Boots M; Buckling A
    Curr Biol; 2015 Apr; 25(8):1043-9. PubMed ID: 25772450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering and shaping bacterial diversity through CRISPR.
    Briner AE; Barrangou R
    Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
    Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
    Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
    Bradde S; Mora T; Walczak AM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host diversity limits the evolution of parasite local adaptation.
    Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S
    Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 8. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How adaptive immunity constrains the composition and fate of large bacterial populations.
    Bonsma-Fisher M; Soutière D; Goyal S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7462-E7468. PubMed ID: 30038015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of Self during CRISPR Immunization.
    Weissman JL; Stoltzfus A; Westra ER; Johnson PLF
    Trends Microbiol; 2020 Jul; 28(7):543-553. PubMed ID: 32544441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
    Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immigration of susceptible hosts triggers the evolution of alternative parasite defence strategies.
    Chabas H; van Houte S; Høyland-Kroghsbo NM; Buckling A; Westra ER
    Proc Biol Sci; 2016 Aug; 283(1837):. PubMed ID: 27581884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 17. How bacteria control the CRISPR-Cas arsenal.
    Leon LM; Mendoza SD; Bondy-Denomy J
    Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CRISPR: discovery, mechanism and function.
    Pawluk A; Davidson AR; Maxwell KL
    Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.